World News

COVID cases go down in America, but ‘solid gaps’ in jabs: PAHO | Coronavirus News Plague

The dramatic drop in US COVID-19 cases is a ‘deal’ on vaccination demands, says a senior Pan American Health Organization.

When COVID-19 cases dropped in America, the head of the Pan American Health Organization (PAHO) has promoted more and more opportunities to vaccinate and protect health networks across the region.

At a weekly press conference Wednesday, PAHO Director Carissa Etienne said coronavirus-related deaths on the Caribbean islands of the Bahamas, Haiti, and Trinidad and Tobago were further increased last week.

Last week, PAHO said 1.2 million new cases of coronavirus and 31,000 deaths had been recorded in the region.

“We’ve seen the COVID epidemic go down across the region last month, and provide support to those with health problems,” Etienne said.

But he also said that the share of medical care in Brazil and Colombia is about 90%, “a sign that these areas are at high risk of not receiving the care they need”.

A teacher who has received a Chinese vaccine for CanSino COVID-19 during a vaccination campaign for teachers and school staff in Mexico City, Mexico [Edgard Garrido/Reuters]

Brazil has been the most complex is COVID-19, enrolling more than 439,000 people – second only to the United States, according to a study by Johns Hopkins University.

However, Etienne said a major change had taken place in the US, where the number of cases had dropped dramatically after the country developed its vaccine.

More than 60 percent of American adults have it received a single shot, according to the U.S. Centers for Disease Control and Prevention (CDC), and 73% of 65-year-olds are fully vaccinated.

“The progress we are seeing in the United States is proving that the effectiveness of the COVID vaccine is effective and efficient, but it shows the urgent need for access to vaccines throughout our region,” said Etienne.

More than 400 million coronavirus jabs have been distributed throughout the United States, but the “lion’s share” has gone to the US, he said.

Etienne said the “big opportunities” for vaccination in Latin America and the Caribbean are signs that the “dependence” in the region on foreign countries needs treatment.

Prospects for a Chinese vaccine at Sinopharm in a public university courtyard during a vaccination campaign for people over 50 in La Paz, Bolivia [Juan Karita/AP Photo]

“There is a great need for vaccines in Latin America and the Caribbean, a region that already exists try it it’s this plague. ”

Etienne said only 3 percent of people in Latin America were successful vaccine and stressed the need to increase the potential of the region for vaccination, rather than relying on inputs.

He also said Argentina, Brazil, Mexico and Cuba have manufacturing facilities that are convenient and well-equipped create a COVID-19 vaccine.

“Fortunately, we have some of the factors that can make this happen: strong institutions for education and research, strong manufacturing capacity, strong systems, and procurement mechanisms,” Etienne said.

Brazil he announced this week that he hopes to receive a comprehensive COVID-19 vaccine from China to produce 25 million doses of AstraZeneca and Sinovac.

In Argentina, where the coronavirus is on the rise, Reuters reports that 18% of people have received one jab so far, while 4.5% of Argentines are infected with the virus.

Source link

Related Articles

Leave a Reply

Back to top button